PMID: 6113158Apr 1, 1981Paper

Comparison of the effectiveness of bone marrow and spleen stem cells for platelet repopulation in lethally irradiated mice

Experimental Hematology
M E Bentfeld-Barker, J C Schooley

Abstract

To determine whether stem cells from spleen differ from those of bone marrow in their ability to support platelet repopulation after lethal irradiation we compared normal, splenectomized and plethoric (3 weeks exposure to CO) spleen cell recipients with similar groups of mice reconstituted with comparable numbers of bone marrow stem cells. Female LAF1 mice were given 825-950 R from a 60Co source and were transplanted with 0, 0.5, 1, 2, or 4 x 10(6) bone marrow or 10-64 x 10(6) spleen cells. CFUs content of the transplant was calculated from day 9 splenic nodules in mice receiving 5 x 10(4) bone marrow or 1.0-1.6 x 10(6) spleen cells. Blood volumes, platelet counts and hematocrits were determined on day 12. Total circulating platelets increased with increasing stem cell dose (range 50-1000 CFUs) after both types of transplant. Plethoric mice always had lower platelet levels than controls even when corrected for expanded blood volume. There was little difference between values for normal and splenectomized mice. Platelet production per CFUs in all groups except splenectomized spleen cell recipients declined with large transplants presumably because of feedback inhibition. Although the number of splenic megakaryocytes in spleen ce...Continue Reading

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.